Occudo Quantitative Strategies’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-10,398
Closed -$72.4K 686
2025
Q3
$72.4K Buy
+10,398
New +$73.3K 0.01% 636
2023
Q1
Sell
-47,369
Closed -$558K 897
2022
Q4
$558K Buy
47,369
+13,187
+39% +$151K 0.07% 467
2022
Q3
$315K Buy
34,182
+21,691
+174% +$263K 0.02% 830
2022
Q2
$123K Buy
+12,491
New +$252K 0.01% 993
2022
Q1
Sell
-9,404
Closed -$468K 1123
2021
Q4
$468K Buy
9,404
+1,390
+17% +$73.2K 0.04% 635
2021
Q3
$369K Buy
+8,014
New +$318K 0.04% 657

Other funds holding ASPN

Occudo Quantitative Strategies's ASPN Position: Q4 2025 in Review

Occudo Quantitative Strategies sold out of Aspen Aerogels (ASPN) in Q4 2025, closing a stake of 10,398 shares — an estimated $72.4K sold.

Occudo Quantitative Strategies first reported a position in ASPN in Q3 2021 and held it in 6 quarters. The position peaked at $558K in Q4 2022. 183 funds tracked by Wall St. Rank hold ASPN as of Q4 2025.

  • Occudo Quantitative Strategies reported no remaining Aspen Aerogels position as of Q4 2025 after selling out during the quarter.
  • Occudo Quantitative Strategies sold 10,398 Aspen Aerogels shares in Q4 2025, an estimated $72.4K.
  • Occudo Quantitative Strategies first reported a position in Aspen Aerogels in Q3 2021 and held it in 6 quarters.
  • Occudo Quantitative Strategies's Aspen Aerogels position peaked at $558K in Q4 2022.
  • 183 funds tracked by Wall St. Rank held Aspen Aerogels as of Q4 2025.

Based on Occudo Quantitative Strategies's 13F filing for Q4 2025, filed 17 Feb 2026.